Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Current Assets (2016 - 2025)

China Pharma Holdings filings provide 16 years of Current Assets readings, the most recent being $2.3 million for Q4 2025.

  • On a quarterly basis, Current Assets fell 28.25% to $2.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.3 million, a 28.25% decrease, with the full-year FY2025 number at $2.3 million, down 28.25% from a year prior.
  • Current Assets hit $2.3 million in Q4 2025 for China Pharma Holdings, up from $2.3 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $9.1 million in Q4 2021 to a low of $2.3 million in Q3 2025.
  • Median Current Assets over the past 5 years was $5.2 million (2021), compared with a mean of $5.0 million.
  • Biggest five-year swings in Current Assets: skyrocketed 70.87% in 2021 and later crashed 45.47% in 2024.
  • China Pharma Holdings' Current Assets stood at $9.1 million in 2021, then plummeted by 34.41% to $6.0 million in 2022, then rose by 0.54% to $6.0 million in 2023, then tumbled by 45.47% to $3.3 million in 2024, then fell by 28.25% to $2.3 million in 2025.
  • The last three reported values for Current Assets were $2.3 million (Q4 2025), $2.3 million (Q3 2025), and $2.7 million (Q2 2025) per Business Quant data.